With DiGAs and DiPAs established medical device manufacturers and pharmaceutical companies can get closer to patients and providers, implement digital, data-driven business models, create a strong competitive advantage and create new revenue streams.

Zühlke is your strategic partner for the development of DiGAs and DiPAs - from the initial idea to approval and operation. Either by co-development with startups or by creating your own digital solutions from scratch - with us you minimize your risks and optimize time-to-market. Like this, you can expand your existing portfolio quickly and securely by digital, patient-centric solutions and establish holistic therapy solutions.

DiGAs and DiPAs are considered as one of the biggest breakthroughs in the digitalization of the German healthcare system. But for a lot of companies, some quite important questions remain unanswered:

• How can you benefit from this trend as an established Medtech or Pharma company?
• What is the best approach when developing new digital offerings?
• What (regulatory) obligations and risks need to be considered?
• What are the most promising business cases?
• How can you ensure a successful collaboration with innovative ‘Tech’ partners?

To answer questions like these, it is helpful to have an experienced partner who approaches digital health innovation holistically.

• Complement your existing product portfolio quickly and with minimal risk by digital solutions (DiGAs, DiPAs), which are internationally compliant (incl. approval according to MDR and FDA).
• Make a strategic decision to realize your own ideas, to enter partnerships or to buy solutions or providers.
• Extend software solutions and digital health platforms with self-developed devices - all from a single trusted partner (e.g. drug delivery systems, diagnostic devices, wearables, ...) 

We enable you to become successful with digital health solutions quickly and with minimal risk.